AInvest★★★★★3-DAY FREE
Catch pre-market movers with AI signals.
Claim Trial
--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About SION20270115C7.5
Chemical and pharmaceutical
Sionna Therapeutics, Inc., was incorporated under the laws of the State of Delaware in August 2019. The company is a clinical-stage biopharmaceutical company whose mission is to revolutionize the current treatment model for cystic fibrosis patients by developing new drugs that normalize the function of cystic fibrosis transmembrane conductance regulator proteins and provide clinically meaningful benefits to patients with CF.
